Explore All 10210 Add-on Acquisition Internet Software and Services Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | March 29, 2022 |
| Target | BioStrand |
| Sector | Internet Software and Services |
| Buyer(s) | ImmunoPrecise |
| Deal Type | Add-on Acquisition |
| Deal Value | 20M EUR |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1983 |
| Sector | Life Science |
| Employees | 102 |
| Revenue | 25M CAD (2025) |
ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise was founded in 1983 and is based in Victoria, Canada.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Internet Software and Services | 1 of 1 |
| Type: Add-on Acquisition | 2 of 2 |
| Country: Belgium | 1 of 1 |
| Year: 2022 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-04-06 |
ModiQuest Research BV
Oss City, Netherlands ModiQuest Research BV is an antibody solutions company focused on the next generation of technology behind therapeutic antibody discovery. ModiQuest Research is based in Oss City, Netherlands. |
Buy | CA$750K |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-20 |
Carterra s LSA Instrument
Salt Lake City, Utah, United States Carterra's LSA Instrument which allows for high throughput surface plasmon resonance-based antibody characterizations thereby significantly increasing the Company’s capacity in performing various label-free protein interaction analyses including best-in-class kinetics, epitope binning, quantitation, epitope mapping, and blocking/neutralization assays. |
Buy | - |
